Results 21 to 30 of about 2,425 (160)

CONDITION OF LIPID PEROXIDATION IN HYPERTENSIVES WITH A YEAR-LONG TREATMENT WITH MIFEBRADIL, FOSINOPRIL AND DOXASOSINE

Российский кардиологический журнал, 2000
Condition of lipid peroxidation in hypertensives with a year-long treatment with mifebradil, fosinopril and doxasosine.
V. A. Orlov, A. I. Trankin, S. I. Afonin
doaj   +1 more source

Fosinopril – a drug of choice in chronic heart failure prevention and treatment [PDF]

Кардиоваскулярная терапия и профилактика, 2006
Aim. To study ACE inhibitor fosinopril effects on remodeling, diastolic filling of left and right ventricles (LV, RV), ectopic myocardial activity, heart rate variability, endothelial function, and microcirculation in patients with arterial hypertension (
N. Yu. Khosyainova, V. M. Tsareva, O. V. Sukharukova, I. V. Milyagina   +3 more
doaj   +1 more source

Effect of Tangshen formula on alleviating oxidative renal injury in UUO mice by downregulated expression of NADPH oxidase

Journal of Radiation Research and Applied Sciences, 2022
Objective: To explore the effect of Tangshen formula on the oxidative renal injury in UUO mice. Method: Seven-week-old male mice C57BL/6N were selected and randomly divided into sham-surgery group, UUO model group (UUO-7d and UUO-14d), Tangshen formula ...
Xinyu Ding, Ping Li, Chao Tan, Liwei Wang, Peng Liu, Xuefeng Zhou, Yu Bai, Yingbo Guo, Chengcheng Zhang   +8 more
doaj   +1 more source

THE DYNAMICS OF 0,1 HZ-COMPONENT OF HEART RATE VARIABILITY AT PATIENTS WITH ARTERIAL HYPERTENSION AT TREATMENT BY FOSINOPRIL AND ATENOLOL [PDF]

Саратовский научно-медицинский журнал, 2008
Aim: to study dynamics of the 0,1Hz-componentofthe heart rate variability(HRV) spectrum in patients with arterial hypertension taking fosinopril and atenolol. 49 patients with hypertension were enrolled (age - 46+/-7 years).
A.N. Strunina, O.M. Posnenkova, V.I. Gridnev, A.R. Kiselev, O.V. Shevchenko, A.A. Svistunov   +5 more
doaj  

FOSINOPRIL, A POTENTIAL SUBSTRATE FOR MRP2, COMPETES WITH SEVERAL HIGH USE PHARMACEUTICALS FOR ELIMINATION [PDF]

, 2010
The multidrug-resistance associated protein 2 (MRP2) is a membrane-bound transporter responsible for the efflux of a variety of drugs and endogenous compounds.
Green, Benjamin
core   +1 more source

Fosinopril Overdose in an Infant

, 1999
Objective: To report an accidental fosinopril overdose in an infant. Case Summary: A 20-month-old African-American girl ingested approximately 16 mg/kg of fosinopril.
Kimberly A Stokes, Steven L Lanski, Jerrold B Leikin   +2 more
core   +1 more source

Application of PNR Detection in the Diagnosis and Drug-efficacy Evaluation of Diabetic Kidney Disease in Rats

Shiyan dongwu yu bijiao yixue
Objective This study aims to monitor the mRNA ratio of podocin to nephrin (PNR) in glomerular podocytes of early diabetic kidney disease (DKD) rat models. The feasibility of using PNR as an early diagnostic indicator for DKD was evaluated by comparing it
ZHANG Naiqun, YUAN Piaopiao, CAO Linrong, YING Na, YANG Taotao   +4 more
doaj   +1 more source

Development and validation of a UV-spectrophotometric method for determination of an ACE inhibitor in pharmaceutical formulations [PDF]

Folia Medica
Introduction: Fosinopril sodium, an angiotensin-converting enzyme inhibitor, is a widely prescribed antihypertensive agent and one of the leading drugs approved for use in hypertension management.
Yana Gvozdeva
doaj   +3 more sources

Fosinopril Versus Amlodipine Comparative Treatments Study

, 2002
Background — ACE inhibitors and calcium antagonists may modulate fibrinolysis. We conducted a randomized controlled
Grant W. Somes, Lonneke V. Franse, William C. Cushman, Karen C. Johnson, Russell P. Tracy, Steven R. Deitcher, William B. Applegate, Marco Pahor, Ronald I. Shorr, Kandice Kottke-Marchant   +9 more
core   +1 more source

Cardiovascular Diseases: Exploring Epidemiology, Pathophysiology, Risk Factors, and Medicinal Plant‐Based Therapies: A Narrative Review

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality, encompassing coronary artery disease, hypertension, heart failure, and cerebrovascular disorders. The global burden of CVD continues to rise, driven by complex interactions among endothelial dysfunction, oxidative stress, inflammation,
Nawfal Hasan Siam, Umme Halima Mithila, Sadia Alam Tisha, Hridoy Saha, Ayesha Binte Mahbub, Farhan Nizam, Johirul Islam, Noushin Tabasumma, Md. Mazharul Islam Chowdhury   +8 more
wiley   +1 more source